Our Community
Latest Photos
Latest Videos
Our Blog
Latest Events
Tuesday, 16 August 2016 07:46

General Overview of the 13th TECAM Conference Time for a Global Initiative in 2016

Andreu M. Climent, Ricardo Sanz-Ruiz, María Eugenia Fernández-Santos, Adolfo Villa Arranz, Francisco Fernández-Avilés
Department of Cardiology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense-Facultad de Medicina, Madrid, Spain.
Circ Res. 2016 Jul 22;119(3):409-13. doi: 10.1161/CIRCRESAHA.116.309337. [Pub Med] [Texto completo]


More than 20 years after the introduction of stem cells as a potential tool for cardiovascular regenerative medicine (CRM), the possibility of modulating cardiac regeneration in humans is still considered the most promising alternative to overcome the limitations of existent treatments for cardiovascular failure. However, CRM has not yet showed clear improvements over standard therapies in terms of clinical outcomes. Therefore, there is a compelling need and willingness among clinicians and scientists to discuss progress and hurdles of CRM in an open forum. This has been the aim of the International Symposium on Cell Therapy and Cardiovascular Innovations (TECAM, since its inception 14 years ago. The latest edition of the TECAM conference was held in Madrid last May 12th and 13th. During the meeting, recent breakthroughs, open questions, and future steps were debated by the main experts worldwide and are summarized in this article.

This website use cookies to offer a better service. If you continue browsing, you accept using cookies. Accept cookies permission.